Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease
WH Ma, AF Chen, XY Xie, YS Huang - Neuropharmacology, 2021 - Elsevier
Alzheimer's disease (AD) is an age-related neurodegenerative disease and characterized
by dementia, memory decline, loss of learning and cognitive disorder. The main pathological …
by dementia, memory decline, loss of learning and cognitive disorder. The main pathological …
Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease
WH Ma, AF Chen, XY Xie, YS Huang - Neuropharmacology, 2021 - Elsevier
Alzheimer's disease (AD) is an age-related neurodegenerative disease and characterized
by dementia, memory decline, loss of learning and cognitive disorder. The main pathological …
by dementia, memory decline, loss of learning and cognitive disorder. The main pathological …
Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease.
WH Ma, AF Chen, XY Xie, YS Huang - Neuropharmacology, 2020 - europepmc.org
Alzheimer's disease (AD) is an age-related neurodegenerative disease and characterized
by dementia, memory decline, loss of learning and cognitive disorder. The main pathological …
by dementia, memory decline, loss of learning and cognitive disorder. The main pathological …
Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease
WH Ma, AF Chen, XY Xie… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is an age-related neurodegenerative disease and characterized
by dementia, memory decline, loss of learning and cognitive disorder. The main pathological …
by dementia, memory decline, loss of learning and cognitive disorder. The main pathological …